ES2052579T3 - Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida. - Google Patents
Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida.Info
- Publication number
- ES2052579T3 ES2052579T3 ES87309312T ES87309312T ES2052579T3 ES 2052579 T3 ES2052579 T3 ES 2052579T3 ES 87309312 T ES87309312 T ES 87309312T ES 87309312 T ES87309312 T ES 87309312T ES 2052579 T3 ES2052579 T3 ES 2052579T3
- Authority
- ES
- Spain
- Prior art keywords
- human recombinant
- manufacture
- interferon alpha
- medicinal product
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A PACIENTES INFECTADOS CON EL VIRUS QUE PRODUCE SIDA, HTLV-III, SE ADMINISTRAN DOSIS ALTAS DE INTERFERON ALFA RECOMBINANTE, QUE SON SUFICIENTES PARA HACER A LOS PACIENTES AVIREMICOS. LAS ALTAS DOSIS PUEDEN OSCILAR DESDE APROXIMADAMENTE 5 A 75 MILLONES DE UNIDADES INTERNACIONALES DE INTERFERON (ALFA)-2, PREFERIBLEMENTE (ALFA)-2B RECOMBINANTE, POR DIA POR INYECCION. LOS PACIENTES SE PUEDEN MANTENER EN UN ESTADO AVIREMICO, MANTENIENDO UN REGIMEN DE DOSIS DE 10 A 35 MILLONES DE UNIDADES INTERNACIONALES APROSIMADAMENTE, EN DOSIS SENCILLAS, DE 3 A 7 DIAS POR SEMANA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92192286A | 1986-10-22 | 1986-10-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2052579T3 true ES2052579T3 (es) | 1994-07-16 |
Family
ID=25446188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87309312T Expired - Lifetime ES2052579T3 (es) | 1986-10-22 | 1987-10-21 | Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0266940B1 (es) |
JP (1) | JPS63104929A (es) |
AT (1) | ATE83381T1 (es) |
CA (1) | CA1297788C (es) |
DE (1) | DE3783122T2 (es) |
ES (1) | ES2052579T3 (es) |
GR (1) | GR3006999T3 (es) |
OA (1) | OA08768A (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL100415A0 (en) * | 1990-12-21 | 1992-09-06 | Schering Corp | Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases |
MX9307733A (es) * | 1992-12-23 | 1994-06-30 | Schering Corp | Restauracion de la funcion inmunologica en pacientes asintomaticos de vih-positivo. |
FR2713657B1 (fr) * | 1993-12-13 | 1996-03-01 | Transgene Sa | Nouveaux vecteurs pour le traitement du sida. |
WO2009134754A1 (en) | 2008-04-28 | 2009-11-05 | Janssen Pharmaceutica Nv | Benzoimidazole glycinamides as prolyl hydroxylase inhibitors |
MX344109B (es) | 2011-10-25 | 2016-12-05 | Janssen Pharmaceutica Nv | Formulaciones de sal de meglumina del ácido 1-(5,6-dicloro-1h-benz o[d]imidazol-2-il)-1h-pirazol-4-carboxílico. |
-
1987
- 1987-10-21 OA OA59213A patent/OA08768A/xx unknown
- 1987-10-21 DE DE8787309312T patent/DE3783122T2/de not_active Revoked
- 1987-10-21 CA CA000549813A patent/CA1297788C/en not_active Expired - Lifetime
- 1987-10-21 ES ES87309312T patent/ES2052579T3/es not_active Expired - Lifetime
- 1987-10-21 AT AT87309312T patent/ATE83381T1/de active
- 1987-10-21 EP EP87309312A patent/EP0266940B1/en not_active Revoked
- 1987-10-22 JP JP62267607A patent/JPS63104929A/ja active Pending
-
1993
- 1993-02-10 GR GR930400243T patent/GR3006999T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0266940A1 (en) | 1988-05-11 |
DE3783122T2 (de) | 1993-04-22 |
ATE83381T1 (de) | 1993-01-15 |
GR3006999T3 (es) | 1993-06-30 |
CA1297788C (en) | 1992-03-24 |
EP0266940B1 (en) | 1992-12-16 |
OA08768A (fr) | 1989-03-31 |
DE3783122D1 (de) | 1993-01-28 |
JPS63104929A (ja) | 1988-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9302160A (es) | Composiciones farmaceuticas del interferon de leu cocito humano concordante. | |
KR890700035A (ko) | 개량된 인터페론 요법 | |
IL87621A0 (en) | Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them | |
KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
DK602988D0 (da) | Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser | |
PE72799A1 (es) | Interferones polietilen glicol modificados | |
FI891774A0 (fi) | Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi | |
ES2052579T3 (es) | Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida. | |
ES2051710T3 (es) | Utilizacion de d-fenfluramina para la fabricacion de medicamentos para el tratamiento de depresiones. | |
ES2061496T3 (es) | Tratamiento intralesional del carcinoma de celulas basales con alfa-interferon humano recombinante. | |
FI954127A (fi) | Menetelmä C-hepatiitin hoitamiseksi interferonihoitoon reagoimattomissa potilaissa | |
ES2058555T3 (es) | Medicamento para el tratamiento intralesional del carcinoma de celulas escamosas, con alfa-interferon humano recombinante. | |
DK374388A (da) | Immunterapeutisk, oral interferondosisform samt fremgangsmaade til fremstilling heraf | |
IT1284852B1 (it) | Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da | |
IT1283945B1 (it) | Uso dell'interferone alfa naturale umano da cellule linfoblastoidi per la terapia delle epatiti virali, neoplasie e sindromi da | |
KR920014480A (ko) | 기흉 치료용 제약 조성물을 제조하기 위한 인간 인터류킨 2의 활성을 갖는 폴리펩티드의 용도 | |
TH29406B (th) | องค์ประกอบสำหรับการบำบัดโรคตับอักเสบ บี | |
TH15782A (th) | องค์ประกอบสำหรับการบำบัดโรคตับอักเสบ บี | |
TH33852A (th) | การกระตุ้นกลไกป้องกันของโฮลท์ในการต่อต้านการประลองด้วยไวรัส | |
MY101495A (en) | Treatment of diseases caused by viruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 266940 Country of ref document: ES |